查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1310254

组织工程为基础的皮肤替代品市场：副产品（生物、生物合成、合成）、用途（急性伤口、慢性伤口）和最终用途- COVID-19、俄罗斯-乌克兰衝突和高累积的累积影响 - 世界预测2023 -2030

Tissue Engineered Skin Substitutes Market by Product (Biological, Biosynthetic, Synthetic), Application (Acute Wounds, Chronic Wounds), End Use - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

全球组织工程皮肤替代品市场预计将大幅成长，预计到 2023 年将达到 112,075 万美元，年复合成长率为 12.58%，到 2030 年将达到 258,058 万美元。

FPNV定位矩阵

FPNV定位矩阵对于评估全球基于组织工程的皮肤替代品市场至关重要。透过检验业务策略和产品满意度等关键指标，它可以对供应商进行全面评估，使用户能够根据自己的特定需求做出资讯的决策。这种进阶分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市占率分析

市场占有率分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对总收入、基本客群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、累积和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场的渗透率。

3. 市场多元化：提供有关新产品发布、未开发地区、最新发展和投资的详细资讯。

4.市场趋势：全面了解COVID-19、俄罗斯-乌克兰衝突和高通膨的累积影响。

5.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

6. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题：

1.基于组织工程的皮肤替代品的全球市场规模和预测是多少？

2.在预测期内，COVID-19对全球基于组织工程的皮肤替代品市场的阻碍因素和影响是什么？

3. 在预测期内，全球基于组织工程的皮肤替代品市场需要投资哪些产品/细分市场/应用/领域？

4. 全球组织工程皮肤替代品市场的竞争策略是什么？

5. 全球组织工程皮肤替代品市场的技术趋势和法律规范是什么？

6.全球组织工程皮肤替代品市场主要供应商的市占率是多少？

7. 哪些型态和策略措施被认为适合进入组织工程皮肤替代品的全球市场？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

  • 市场动态
    • 促进因素
      • 急性和慢性伤口的盛行率上升
      • 植皮需求增加
      • 皮肤再生技术的进步
    • 抑制因素
      • 皮肤附属器再生能力有限
    • 机会
      • 医疗保健领域的技术进步与研发投资
      • 公私伙伴关係促进及扩大市场普及
    • 任务
      • 缺乏支持性报销政策
  • 市场趋势
  • COVID-19 的累积影响
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范
  • 客户客製化

第6章基于组织工程的皮肤替代品市场：副产品

  • 生物
  • 生物合成
  • 合成

第7章基于组织工程的皮肤替代品市场：依用途

  • 急性伤口
    • 烧伤
    • 手术与创伤
  • 慢性伤口
    • 糖尿病足溃疡
    • 其他慢性伤口
    • 褥疮
    • 腿部静脉性溃疡

第8章基于组织工程的皮肤替代品市场：按最终用途

  • 医院
  • 创伤护理中心

第9章美洲基于组织工程的皮肤替代品市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太地区以组织工程为基础的皮肤替代品市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第11章欧洲、中东和非洲的组织工程皮肤替代品市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第12章竞争形势

  • FPNV定位矩阵
  • 市占率分析：主要企业
  • 竞争情境分析：主要企业

第13章上市公司名单

第14章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-0360AB17E1AA

The Global Tissue Engineered Skin Substitutes Market is forecasted to grow significantly, with a projected USD 1,120.75 million in 2023 at a CAGR of 12.58% and expected to reach a staggering USD 2,580.58 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Tissue Engineered Skin Substitutes Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Tissue Engineered Skin Substitutes Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Biological, Biosynthetic, and Synthetic. The Biological is projected to witness significant market share during forecast period.

Based on Application, market is studied across Acute Wounds and Chronic Wounds. The Acute Wounds is further studied across Burn Injuries and Surgery & Trauma. The Chronic Wounds is further studied across Diabetic Foot Ulcers, Other Chronic Wounds, Pressure Ulcers, and Venous Leg Ulcers. The Chronic Wounds is projected to witness significant market share during forecast period.

Based on End Use, market is studied across Hospitals and Wound Care Centers. The Wound Care Centers is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Tissue Engineered Skin Substitutes Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Tissue Engineered Skin Substitutes Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Tissue Engineered Skin Substitutes Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Tissue Engineered Skin Substitutes Market?

4. What is the competitive strategic window for opportunities in the Global Tissue Engineered Skin Substitutes Market?

5. What are the technology trends and regulatory frameworks in the Global Tissue Engineered Skin Substitutes Market?

6. What is the market share of the leading vendors in the Global Tissue Engineered Skin Substitutes Market?

7. What modes and strategic moves are considered suitable for entering the Global Tissue Engineered Skin Substitutes Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Tissue Engineered Skin Substitutes Market, by Product, 2022 vs 2030
  • 4.3. Tissue Engineered Skin Substitutes Market, by Application, 2022 vs 2030
  • 4.4. Tissue Engineered Skin Substitutes Market, by End Use, 2022 vs 2030
  • 4.5. Tissue Engineered Skin Substitutes Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of acute and chronic wounds
      • 5.1.1.2. Increased demand for skin grafts
      • 5.1.1.3. Advances in skin regeneration technology
    • 5.1.2. Restraints
      • 5.1.2.1. Limited ability to reproduce skin appendages
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements and R&D investment in healthcare
      • 5.1.3.2. Public-private alliance to promote and increase penetration in market
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of supportive reimbursement policies
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Tissue Engineered Skin Substitutes Market, by Product

  • 6.1. Introduction
  • 6.2. Biological
  • 6.3. Biosynthetic
  • 6.4. Synthetic

7. Tissue Engineered Skin Substitutes Market, by Application

  • 7.1. Introduction
  • 7.2. Acute Wounds
    • 7.2.1. Burn Injuries
    • 7.2.2. Surgery & Trauma
  • 7.3. Chronic Wounds
    • 7.3.1. Diabetic Foot Ulcers
    • 7.3.2. Other Chronic Wounds
    • 7.3.3. Pressure Ulcers
    • 7.3.4. Venous Leg Ulcers

8. Tissue Engineered Skin Substitutes Market, by End Use

  • 8.1. Introduction
  • 8.2. Hospitals
  • 8.3. Wound Care Centers

9. Americas Tissue Engineered Skin Substitutes Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Tissue Engineered Skin Substitutes Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Tissue Engineered Skin Substitutes Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET RESEARCH PROCESS
  • FIGURE 2. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, 2022 VS 2030
  • FIGURE 3. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 5. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 6. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2022 VS 2030 (%)
  • FIGURE 7. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET DYNAMICS
  • FIGURE 9. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 5. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY BIOLOGICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY BIOSYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 9. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 10. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY BURN INJURIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY SURGERY & TRAUMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 14. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY DIABETIC FOOT ULCERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY OTHER CHRONIC WOUNDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRESSURE ULCERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY VENOUS LEG ULCERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 20. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY WOUND CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 70. INDIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. INDIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 75. INDONESIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. INDONESIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 80. JAPAN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. JAPAN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 85. MALAYSIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. MALAYSIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 90. PHILIPPINES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. PHILIPPINES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. PHILIPPINES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 95. SINGAPORE TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. SINGAPORE TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. SINGAPORE TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 100. SOUTH KOREA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. SOUTH KOREA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. SOUTH KOREA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 105. TAIWAN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. TAIWAN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. TAIWAN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 110. THAILAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. THAILAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. THAILAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 115. VIETNAM TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. VIETNAM TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. VIETNAM TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 126. DENMARK TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. DENMARK TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. DENMARK TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 131. EGYPT TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. EGYPT TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. EGYPT TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 136. FINLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. FINLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. FINLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 141. FRANCE TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. FRANCE TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. FRANCE TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 146. GERMANY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. GERMANY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. GERMANY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 151. ISRAEL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. ISRAEL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. ISRAEL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 156. ITALY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. ITALY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. ITALY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 161. NETHERLANDS TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. NETHERLANDS TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. NETHERLANDS TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 166. NIGERIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. NIGERIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. NIGERIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 171. NORWAY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. NORWAY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. NORWAY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 176. POLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. POLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. POLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 181. QATAR TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. QATAR TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. QATAR TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 186. RUSSIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. RUSSIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. RUSSIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 191. SAUDI ARABIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. SAUDI ARABIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. SAUDI ARABIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 196. SOUTH AFRICA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 197. SOUTH AFRICA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH AFRICA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 201. SPAIN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 202. SPAIN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. SPAIN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 206. SWEDEN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 207. SWEDEN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. SWEDEN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 211. SWITZERLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 212. SWITZERLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 213. SWITZERLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 216. TURKEY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 217. TURKEY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 218. TURKEY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 221. UNITED ARAB EMIRATES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 222. UNITED ARAB EMIRATES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. UNITED ARAB EMIRATES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED KINGDOM TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED KINGDOM TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED KINGDOM TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY ACUTE WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY CHRONIC WOUNDS, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 231. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 232. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 233. TISSUE ENGINEERED SKIN SUBSTITUTES MARKET LICENSE & PRICING